German Multicenter Study Investigating177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Journal of Nuclear Medicine - Tập 58 Số 1 - Trang 85-90 - 2017
Kambiz Rahbar1, Hojjat Ahmadzadehfar2, Clemens Kratochwil3, Uwe Haberkorn3, Michael Schäfers1, Markus Essler2, Richard P. Baum4, Harshad Kulkarni4, Matthias Schmidt5, Alexander Drzezga5, Peter Bartenstein6, Andreas Pfestroff7, Markus Luster7, Ulf Lützen8, Marlies Marx8, Vikas Prasad9, Winfried Brenner9, Alexander Heinzel10, Felix M. Mottaghy10, Juri Ruf11, Philipp T. Meyer11, Martin Heuschkel12, Maria Eveslage13, Martin Boegemann14, Wolfgang P. Fendler6, Bernd J. Krause12,15
1Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany
2Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany
3Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
4Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany
5Department of Nuclear Medicine, University of Cologne, Cologne, Germany
6Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
7Department of Nuclear Medicine, University of Marburg, Marburg, Germany
8Department of Nuclear Medicine, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany
9Department of Nuclear Medicine, Charite, University Hospital Berlin, Berlin, Germany
10Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany
11Department of Nuclear Medicine, University of Freiburg, Freiburg, Germany
12Department of Nuclear Medicine, University of Rostock, Rostock, Germany
13Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany
14Department of Urology, University Hospital Muenster, Muenster, Germany
15German Society of Nuclear Medicine Göttingen, Göttingen, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3322/caac.21332

10.3322/caac.20073

10.1002/jcb.10661

10.1007/s00259-012-2298-2

10.2967/jnumed.115.154153

10.1007/s00259-013-2489-5

10.1007/s00259-014-2949-6

10.2967/jnumed.115.169243

10.1007/s00259-016-3346-0

Eiber M Weirich G Holzapfel K . Simultaneous Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer. Eur Urol. January 18, 2016 [Epub ahead of print].

10.2967/jnumed.114.147413

Ahmadzadehfar, 2015, Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study, EJNMMI Res., 5, 114, 10.1186/s13550-015-0114-2

Ahmadzadehfar, 2016, Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer, Oncotarget., 7, 12477, 10.18632/oncotarget.7245

10.2967/jnumed.115.171397

10.2967/jnumed.116.173757

10.1097/RLU.0000000000001240

10.1200/JCO.2015.64.2702

10.1056/NEJMoa1315815

10.1016/j.eururo.2014.07.028

10.1093/annonc/mdt138

10.1056/NEJMoa1213755

10.1016/S0140-6736(10)61389-X

10.1158/1078-0432.CCR-13-0231

10.1186/1748-717X-6-125

10.1200/JCO.2011.35.8648

Thông tin
Thông tin xuất bản

Journal of Nuclear Medicine

Tập 58 Số 1

85-90

Thông tin tác giả